I co-wrote this piece with Dr. Jeffrey Chen, a Harvard-trained emergency medicine physician who now practices longevity medicine as Founding Medical Director of Peak Health. Over the course of our conversations, one patient story kept coming back — and it captures why the way we practice needs to change. Her name, age, and other details are altered for privacy, though the overall story is true.
Sarah was 42 years old, a devoted mother, and by every standard measure, healthy. Her annual checkup looked reassuring: normal blood pressure, normal cholesterol by traditional standards. She ate well and frequently ran 5k races. Her family physician ran her numbers through the standard risk calculators used across American medicine and concluded what most doctors would: she didn’t qualify for further cardiac workup.
But Sarah had a family secret hiding in plain sight. Her father had suffered a massive heart attack and died at age 52. That nagging detail, a history that traditional risk models consider though tend to underweight, was the thread that unraveled everything.
‘ I needed to take a different approach’, Dr Chen said. He ordered a coronary artery calcium scan, a quick, low-radiation CT scan that directly images the heart’s arteries for calcium deposits, looking for the buildup that hardens inside artery walls over years.
The results were staggering. Sarah, at 42, with “normal” cholesterol and a clean bill of health, had significant calcium buildup in her coronary arteries. Her arteries were already narrowing with the kind of disease that, left unchecked, leads to the very heart attack that had killed her father.
A coronary CT angiogram followed— a more detailed scan that creates a 3D picture of the arteries. This scan revealed that Sarah had both soft plaque and hard plaque.
Hard plaque is the calcified, stable buildup that narrows arteries over time. Soft plaque is the more dangerous finding. It’s the type that can rupture suddenly, triggering a blood clot that blocks blood flow entirely. That’s what causes a “surprise” heart attack — one that strikes someone who felt perfectly fine the day before.
Sarah’s heart disease was not a future risk. It was a present reality — one that traditional medicine had missed entirely.
The Gap That Longevity Medicine Was Built To Close
Stories like Sarah’s are not rare. They are disturbingly common. Heart disease remains the leading cause of death worldwide, and too many of its victims never see it coming.
In his years as an emergency medicine physician, Dr. Chen saw this pattern play out over and over — patients as young as 35 arriving with heart attacks that were, in hindsight, preventable. “The tragedy was never what happened in the emergency department,” he told me. “The tragedy was that their care started far too late.”
It’s a sentiment I encounter constantly in my own work at the intersection of clinical medicine and health innovation. We have built an extraordinary healthcare system for treating acute illness. We haven’t built — at least not at scale — a system for catching disease before it becomes acute.
Professional societies have made important strides, updating their guidelines to incorporate risk-enhancing factors much deeper beyond basic cholesterol numbers — family history, inflammatory markers, coronary calcium scores. These are meaningful steps. But longevity medicine takes the philosophy further: rather than waiting for risk to accumulate, aiming to find disease at its earliest biological whisper and intervene before it ever becomes dangerous.
For Sarah, that meant aggressive lifestyle changes, targeted medications, and a comprehensive monitoring plan — interventions that are backed by decades of evidence and that can halt or even reverse early-stage coronary artery disease. The heart attack that might have come for her within a decade, just as it came for her father at 52, now has every chance of never arriving at all.
Physician-Led, Technology-Enhanced
Early detection is now possible due to the convergence of advanced diagnostics, continuous data, and advances in artificial intelligence — all in the hands of clinicians who have the time, training, and expertise to actually act on what the data reveals. The physician remains at the center. The technology simply extends how far they can see.
Consider coronary inflammation, the biological spark that ignites heart disease long before plaque even forms. New diagnostic technologies can now quantify inflammation in the coronary arteries from a standard cardiac CT scan, identifying patients at elevated risk even when their arteries appear visually clean. A landmark study published in The Lancet, analyzing 40,000 patients, found that among those with no or minimal coronary plaque, individuals with the highest levels of coronary inflammation — yet zero visible plaque — face up to a 9.5-fold higher risk of cardiac death compared to those with normal inflammation levels. That’s a population that most of conventional medicine doesn’t even know to worry about.
But the technology is only as valuable as the physician interpreting it.
A coronary calcium score sitting in a patient portal without context is just a number. In the hands of a physician trained in longevity or integrative medicine can combine this data with family history, inflammatory biomarkers, continuous glucose monitors, body composition from DEXA scans, cardiorespiratory fitness from VO2 max testing, patterns emerging from wearable devices and help form a prevention paln.
These are the types of models that doctors in these specialties are focused on. Until recently, this caliber of physician-led longevity care was available mainly through concierge practices like Early Medical and Comite, where comprehensive programs can run $150,000 or more a year. Other clinics like Fountain Life, Biograph and Peak Health, where Dr. Chen practices, make these advanced diagnostics easier to access. Other popular services like Function Health and Superpower deliver deep diagnostics and are in the process of building AI health companions, or even an “AI Doctor” that can help decipher these data.
The other benefit from this is that clinicians can focus on what matters most — the patient relationship, clinical judgment, and long-term health strategy. “Intelligent tools” are increasingly helping doctors spend less time on documentation and more time on the person in front of them. Digital AI scribes, for instance, can handle the burden of clinical note-taking — a task that has consumed healthcare providers for the past decade and contributed to epidemic levels of burnout. Meanwhile, the doctor maintains eye contact, asks deeper questions, and gets to connect more deeply with the patient. The technology doesn’t replace the physician. It gives the physician back the time and freedom that modern healthcare demands had stolen.
Putting Patients In the Driver’s Seat
The same technological evolution that helps doctors practice better medicine is also beginning to reshape the patient experience in profound ways.
From smartwatches that track heart rate variability to rings that monitor body temperature trends to continuous glucose monitors that reveal real-time metabolic responses, wearables are generating a deluge of useful health data. Today, many longevity practices integrate this wearable data directly into a patient’s health record, giving their care team a continuous window into daily life rather than a single snapshot taken during an annual visit.
A good example of this is of a patient arriving at an appointment with a sometimes challenging concern, “I’ve been feeling tired”. Physicians can pull up weeks of objective data: disrupted sleep patterns, declining heart rate variability suggesting chronic stress, glucose spikes after meals, blood work showing early signs of insulin resistance and prediabetes. The conversation shifts from reactive guesswork to informed, proactive coaching.
This also means patients become genuine partners in their own health. When a patient can see on their phone that their resting heart rate has been climbing, or that their sleep quality has dropped since they started traveling for work, they arrive at appointments with better questions. They make lifestyle adjustments in real time, not months later. They become, in a word, engaged — and engaged patients have better outcomes across virtually every measure of health.
From Privilege To Public Health
There is an uncomfortable truth at the center of longevity medicine today: much of what I’ve just described — advanced imaging, comprehensive biomarker testing, wearable integration, physicians with the time to think deeply about a single patient — has historically been available only to the wealthy. Concierge medicine, by definition, has been exclusive.
But that is beginning to change, and technology is the reason why.
Telemedicine has already proven that geography need not be a barrier to accessing excellent care. A patient in rural Alabama can now consult with a physician trained at the nation’s top academic medical centers. Digital health platforms can consolidate lab results, imaging, meds, wearable data, and care plans into a single hub that a care team reviews continuously — not just during a 15-minute office visit. It’s a model that companies are building specifically to make physician-led longevity care accessible to people who could never have afforded traditional concierge medicine.
As the cost of advanced diagnostics continues to fall — coronary CT angiograms, for example, are a fraction of the cost of cardiac catheterization and carry far less risk — the economic argument for preventive longevity care grows stronger. Catching Sarah’s heart disease at 42 is not just better medicine. It is dramatically less expensive than treating her heart attack at 52. The same logic applies across the spectrum of chronic disease: metabolic dysfunction caught early through continuous glucose monitoring, cancer risk identified through advanced biomarker and genetic panels, cognitive decline flagged years before symptoms emerge through baseline testing.
The real promise of longevity medicine is not that a small number of affluent patients will live longer. It is that the principles and tools it is pioneering — early detection, continuous monitoring, personalized prevention — will eventually become the standard of care for everyone. Technology is the bridge that makes that transition possible, by making comprehensive care more efficient, more scalable, and ultimately more affordable.
A New Chapter For Prevention
As a physician who has spent my career working to make trusted health information and tools more accessible, I find myself increasingly aligned with the clinicians building this future from the ground up. Dr. Chen left emergency medicine — a field he loved — because he saw too many patients arriving too late. Now, he and his team are working to ensure that for their patients, that late arrival never happens.
The tools exist. Coronary CT angiograms can reveal dangerous blockages years before symptoms. Coronary inflammation analysis can detect risk before plaque even forms. Comprehensive biomarker panels can map an individual’s health trajectory with unprecedented precision.
What is needed now is the will — from clinicians, from health systems, from policymakers — to make these tools accessible to more than just those who can afford a premium concierge doctor. Every Sarah deserves a physician who has the time and the tools to look deeper. Every family deserves the chance to rewrite the story that genetics seemed to have written for them.
Heart attacks in 2026 should not be surprises. Neither should most of the chronic diseases that claim millions of lives each year. The science of early detection and prevention has arrived. Now it’s time to deliver it to the people who need it most.
Hansa Bhargava, M.D. is a physician executive, Forbes contributor, and Chief Clinical Strategy & Innovation leader at Healio. She is an Adjunct Faculty member at Emory University School of Medicine.
Dr. Jeffrey Chen, M.D. is a Harvard-trained emergency medicine physician turned longevity physician and Founding Medical Director of Peak Health.
